These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9342502)

  • 1. Clinical pharmacokinetics of nefazodone.
    Greene DS; Barbhaiya RH
    Clin Pharmacokinet; 1997 Oct; 33(4):260-75. PubMed ID: 9342502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nefazodone: a new antidepressant.
    Ellingrod VL; Perry PJ
    Am J Health Syst Pharm; 1995 Dec; 52(24):2799-812. PubMed ID: 8748566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
    J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the pharmacokinetics of fluvoxamine.
    van Harten J
    Clin Pharmacokinet; 1995; 29 Suppl 1():1-9. PubMed ID: 8846617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
    Barbhaiya RH; Shukla UA; Chaikin P; Greene DS; Marathe PH
    Eur J Clin Pharmacol; 1996; 50(1-2):101-7. PubMed ID: 8739819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety profile of nefazodone.
    Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
    J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
    von Moltke LL; Greenblatt DJ; Granda BW; Grassi JM; Schmider J; Harmatz JS; Shader RI
    Psychopharmacology (Berl); 1999 Jul; 145(1):113-22. PubMed ID: 10445380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
    Barbhaiya RH; Marathe PH; Greene DS; Mayol RF; Shukla UA; Gammans RR; Pittman KA; Robinson D
    J Clin Pharmacol; 1995 Oct; 35(10):974-84. PubMed ID: 8568015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
    J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
    Barbhaiya RH; Shukla UA; Greene DS
    Eur J Clin Pharmacol; 1995; 49(3):221-8. PubMed ID: 8665999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K; Schweizer E; Case WG; DeMartinis N; Greenblatt DJ; Mandos LA; Garcia España FG
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects.
    Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
    Eur J Clin Pharmacol; 1999 Feb; 54(12):923-8. PubMed ID: 10192752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.